Pyrrolidinedithiocarbamate increases the therapeutic index of 5-fluorouracil in a mouse model.
AuthorsBach, Simon P
O'Dwyer, Sarah T
Potten, Christopher S
Coffey, Robert J
AffiliationCancer Research Campaign, Department of Epithelial Biology, The Paterson Institute, Manchester, England.
MetadataShow full item record
AbstractBACKGROUND & AIMS: The thiol-containing antioxidant pyrrolidinedithiocarbamate (PDTC) enhances the cytotoxic efficacy of 5-fluorouracil (5-FU) against human colorectal cancer cell lines in vitro and in vivo. This process appears to be mediated by a sustained increase in p21 expression, independent of p53 function, resulting in growth arrest and apoptosis. We determined whether PDTC augmented 5-FU intestinal toxicity in non-tumor-bearing mice. METHODS: Apoptotic and mitotic indices were measured in the small and large intestine on a cell positional basis at intervals throughout the 72-hour period after administration of 5-FU (40 mg/kg) and PDTC (250 mg/kg). The proportion of crypts regenerating after 5-FU (600-1200 mg/kg) and PDTC (500 mg/kg) was also measured. RESULTS: 5-FU therapy induces substantial apoptotic cell death with simultaneous inhibition of mitotic activity within the small and large intestinal epithelium. PDTC reduces 5-FU-induced apoptotic events in the colon by 49%, predominantly among clonogenic stem and transit cells while promoting the early recovery of mitotic activity. As a consequence, PDTC increased the proportion of regenerating colonic crypts after 5-FU therapy. PDTC did not, however, significantly modulate 5-FU toxicity in the small intestine. CONCLUSIONS: PDTC does not augment the intestinal toxicity of 5-FU and actually protects the colonic mucosa. These results support further investigation of PDTC and related compounds as treatments for colorectal cancer.
CitationPyrrolidinedithiocarbamate increases the therapeutic index of 5-fluorouracil in a mouse model. 2000, 118 (1):81-9 Gastroenterology
- Regional localisation of p53-independent apoptosis determines toxicity to 5-fluorouracil and pyrrolidinedithiocarbamate in the murine gut.
- Authors: Bach SP, Williamson SE, O'Dwyer ST, Potten CS, Watson AJ
- Issue date: 2006 Jul 3
- The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia.
- Authors: Pritchard DM, Potten CS, Hickman JA
- Issue date: 1998 Dec 1
- Chemically-induced apoptosis: p21 and p53 as determinants of enterotoxin activity.
- Authors: Pritchard DM, Jackman A, Potten CS, Hickman JA
- Issue date: 1998 Dec 28
- HTLV-I Tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an anti-oxidant, in adult T cell leukemia cells.
- Authors: Arima N, Arimura K, Tokito Y, Sakaki Y, Matsushita K, Orihara K, Akimoto M, Ozaki A, Kukita T, Hagiwara T, Hamada H, Tei C
- Issue date: 2004 Feb
- Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation.
- Authors: Pritchard DM, Watson AJ, Potten CS, Jackman AL, Hickman JA
- Issue date: 1997 Mar 4